找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Handbook of Anticancer Pharmacokinetics and Pharmacodynamics; Michelle A. Rudek,Cindy H. Chau,Howard L. McLeod Book 2014Latest edition Spr

[復(fù)制鏈接]
樓主: malcontented
41#
發(fā)表于 2025-3-28 14:52:36 | 只看該作者
Pharmacodynamic Modeling, study design optimized not only for the determination of clinical response and toxicity, but also for optimal measure of pharmacokinetic and pharmacodynamic measures. Pharmacodynamic models, study design, and pharmacodynamic biomarkers for anti-cancer clinical trials are discussed.
42#
發(fā)表于 2025-3-28 21:34:35 | 只看該作者
,Verilog – A Tutorial Introduction,s a major role in the NER-pathway because of its damage recognition and excision ability. This chapter will review mechanisms of DNA repair and platinum resistance as it relates to the NER pathway and regulation of ERCC1. A brief discussion on the role of cancer stem cells in platinum resistance is also presented.
43#
發(fā)表于 2025-3-28 23:11:30 | 只看該作者
DNA Repair: ERCC1, Nucleotide Excision Repair, and Platinum Resistance,s a major role in the NER-pathway because of its damage recognition and excision ability. This chapter will review mechanisms of DNA repair and platinum resistance as it relates to the NER pathway and regulation of ERCC1. A brief discussion on the role of cancer stem cells in platinum resistance is also presented.
44#
發(fā)表于 2025-3-29 06:49:05 | 只看該作者
45#
發(fā)表于 2025-3-29 08:39:31 | 只看該作者
Cancer Drug Discovery and Developmenthttp://image.papertrans.cn/h/image/420812.jpg
46#
發(fā)表于 2025-3-29 12:06:33 | 只看該作者
https://doi.org/10.1007/978-1-4614-9135-4Cancer; Pharmacodynamics; Pharmacogenetics; Pharmacokinetics; Pharmacology
47#
發(fā)表于 2025-3-29 19:18:42 | 只看該作者
48#
發(fā)表于 2025-3-29 22:17:41 | 只看該作者
49#
發(fā)表于 2025-3-30 03:55:14 | 只看該作者
50#
發(fā)表于 2025-3-30 04:36:21 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 05:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
西藏| 藁城市| 化州市| 界首市| 恩施市| 博爱县| 绥江县| 吴桥县| 鸡东县| 蓬溪县| 客服| 牡丹江市| 五原县| 平潭县| 汉寿县| 沅陵县| 天镇县| 仁寿县| 衡阳县| 土默特右旗| 黄龙县| 隆子县| 连州市| 镇赉县| 台湾省| 明溪县| 彭山县| 山东| 五河县| 岚皋县| 柏乡县| 荥阳市| 葵青区| 苍南县| 广州市| 文昌市| 乌兰县| 锡林浩特市| 托克托县| 武义县| 池州市|